Copyright Lucid Health Consulting Pty Ltd. All rights reserved. 2020

 

Commercial Strategy

  • ​Stakeholder and Market Sector Mapping
  • Competitive Environment Analysis
  • Advisory Board Preparation
  • Advisory Board Participations
  • Strategic Planning
  • Commercial and Public Tender Development

Market Access

  • Pricing and Reimbursement Strategy
  • Risk Sharing Agreements
  • Post-Market Analyses
  • Price/Volume Impact Analyses
  • Health Technology Assessment​s
    • PBAC Submissions
    • MSAC Submissions
    • PHARMAC Submissions
    • Prostheses List Applications
    • Hospital Formulary Submissions
  • Market Access Feasibility Studies​

Our Services

Regulatory & Statistics

  • ​Regulatory Submissions
    • Orphan Indication
    • Priority Review or Abbreviated Submission
    • New Chemical Entity (NCE)
    • New Biological Entity (NBE)
    • Presubmission Meetings with the TGA
  • Direct and Indirect Statistical Analyses
  • Patient Preference Studies
    • Discrete Choice Analyses
    • Utility Studies
    • Willingness to Pay Studies

Economic Evaluation

  • Health Economic and ​Decision Analytical Models
    • Cost Utility Analyses
    • Cost Effectiveness Analyses
    • Cost Benefit Analyses
    • Cost Minimisation Analyses
  • Budget Impact Models
  • Model Adaptations for Australia and Internationally